Compare FIEE & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FIEE | ONMD |
|---|---|---|
| Founded | 1977 | 2006 |
| Country | Hong Kong | United States |
| Employees | 43 | 23 |
| Industry | Telecommunications Equipment | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.6M | 46.3M |
| IPO Year | N/A | N/A |
| Metric | FIEE | ONMD |
|---|---|---|
| Price | $7.60 | $0.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.3K | ★ 281.3K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $0.31 |
| 52 Week High | $7.95 | $4.22 |
| Indicator | FIEE | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 62.11 | 51.22 |
| Support Level | $2.45 | $0.77 |
| Resistance Level | $7.88 | $0.87 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 76.74 | 26.06 |
FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.